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ABSTRACT 
Introduction: Heavy goods vehicle (HGV) drivers’ exhibit higher than nationally 
representative rates of obesity, and obesity-related co-morbidities, in comparison to other 
occupational groups. Their working environments are not conducive to a healthy lifestyle, 
yet there has been limited attention to health promotion efforts. We have developed a 
Structured Health Intervention For Truckers (the SHIFT programme), a multicomponent, 
theory-driven, health-behaviour intervention targeting physical activity, diet, and sitting in 
HGV drivers. This paper describes the protocol of a cluster randomised controlled trial 
designed to evaluate the effectiveness and cost-effectiveness of the SHIFT programme. 
 
Methods and analysis: HGV drivers will be recruited from a logistics company in the UK. 
Following baseline measurements, depots (clusters) will be randomised to either the 
SHIFT intervention or usual-care control arm (12 clusters in each, average cluster size 14 
drivers). The 6-month SHIFT intervention includes a group-based interactive 6-hour 
education session, worksite champion support, and equipment provision (including a 
Fitbit® and resistance bands/balls to facilitate a ‘cab workout’). Objectively measured total 
daily physical activity (steps/day) will be the primary outcome. Secondary outcomes 
include: objectively measured light-intensity physical activity and moderate-vigorous 
physical activity, sitting time, sleep quality, markers of adiposity, blood pressure, and 
capillary blood markers (HbA1c, LDL-HDL-cholesterol). Self-report questionnaires will 
examine fruit and vegetable intake, psychosocial and work outcomes, and mental health. 
Quality of life and resources used (e.g. GP visits) will also be assessed. Measures will be 
collected at baseline, 6 and 12-months and analysed according to a modified intention-to-
treat principle. A full process evaluation and cost-effectiveness analysis will be conducted. 
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Ethics and dissemination: Ethical approval was obtained from the Loughborough 
University Ethics Approvals Sub-Committee (Reference: R17-P063). Study findings will be 
disseminated through publications in research and professional journals, through 
conference presentations, and to relevant regional and national stakeholders via online 
media and at dissemination events. 
 
Trial Registration: ISRCTN10483894 (date registered: 1st March, 2017) 
 
Strengths and limitations of this study 
x To our knowledge, this is the first RCT to examine the impact of a multicomponent 
intervention targeting individual and environmental barriers faced by HGV drivers to 
lead a healthy lifestyle. 
x The trial will involve a full process evaluation and an economic evaluation. 
x The primary outcome, physical activity, will be objectively measured. 
x Sustainability of the intervention will be examined at 6-months follow-up, following 
completion of the intervention. 
x Due to the nature of the intervention, participants will not be blinded to their treatment 
arm, and there is a risk that the secondary outcome self-report measures may be 
susceptible to reporting bias. 
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INTRODUCTION 
Long-distance heavy goods vehicle (HGV) drivers are exposed to a multitude of health-
related risk factors associated with their occupation; as a result, lorry driving has been 
identified as one of the most hazardous working professions.1 2  Drivers’ working 
environment provides limited opportunities for a healthy lifestyle and unhealthy lifestyle 
behaviours, such as a lack of physical activity, prolonged periods of sedentary behaviour 
(sitting), poor diet, a high prevalence of smoking, high volumes of alcohol consumption, 
and irregular sleeping patterns are widespread among this occupational group.2-5 
Furthermore, long and variable working hours, including shift work, and tight delivery 
schedules within the Logistics and Transport industry contribute to psychological stress 
and sleep deprivation,6 which can lead to metabolic disturbances and further promote the 
uptake of unhealthy behavioural choices.2 5-8 
 
Long-distance drivers exhibit higher than nationally representative rates of obesity, with 
observational data from a sample of HGV drivers from the UK demonstrating that 84% 
were overweight or obese, compared to 75% of males aged 45-54 years reported to be 
overweight/obese nationally.9  Similar data have been reported from US HGV drivers.2 10 
The high rates of overweight and obesity in HGV drivers elevates their risk of numerous 
chronic diseases and conditions, including cardiovascular disease, type 2 diabetes, 
obstructive sleep apnoea and musculoskeletal disorders.1 2 10-13  
 
To compound the high-risk health profile observed in long-distance drivers nationally and 
internationally,1 2 10-12 the driver population in the UK (n = ~300,000) has been identified as 
an ageing workforce (mean age: 48 years).14 A recent Parliamentary report has highlighted 
the ‘demographic time bomb’ the UK logistics industry is currently facing and the health 
impact of an ageing, at-risk, workforce ‘driving a vehicle often referred to as ‘a 40-tonne 
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missile’’.15  The UK logistics sector is also experiencing a short-fall in HGV drivers, with 
barriers to recruitment including the lack of roadside facilities, medical concerns and long 
hours of work.16 Recommendations on how to address this shortfall and attract younger 
employees to the sector include increasing awareness within the industry of the need to 
address driver health risks and health behaviours.15 
 
A systematic review17 of health promotion interventions in truck drivers, including only 8 
studies, observed that the interventions generally led to improvements in health and health 
behaviours. However, it was concluded that the strength of the evidence was limited due 
to poor study designs, with no control groups, small samples and no or limited follow-up 
periods.17 Since the publication of the systematic review, recent studies have examined 
the impacts of a weight loss intervention in US HGV drivers18 and a smartphone 
application on physical activity and diet in Australian HGV drivers.19 Whilst positive findings 
were observed, the studies were limited by relatively small samples and no comparison 
groups.  
 
We have developed a Structured Health Intervention For Truckers (the SHIFT 
programme), a multicomponent, theory driven, health behaviour intervention designed to 
promote positive lifestyle changes in relation to physical activity, diet, and sitting in HGV 
drivers. This intervention has been informed by extensive stakeholder engagement, 
including a qualitative study exploring the perceived barriers to healthy lifestyle behaviours 
in HGV drivers,7 an observational study exploring lifestyle health-related behaviours in 
HGV drivers and markers of health,3 and a pre-post pilot intervention20 with full process 
evaluation.21 Initial pre-post testing of the intervention revealed the SHIFT programme lead 
to favourable changes in physical activity and some markers of health.20 This protocol 
paper describes a study which will build on our earlier work and generate new knowledge 
6 
 
on the effectiveness and cost-effectiveness of the SHIFT programme, evaluated using a 
cluster randomised controlled trial (RCT) design with immediate and extended follow-up. 
Specifically, we will examine the impact of the SHIFT programme on physical activity, 
sedentary behaviour, fruit and vegetable intake, adiposity, sleep duration and quality, risk 
factors for cardio-metabolic disease, psychosocial outcomes and mental health in a 
sample of HGV drivers.  
 
STUDY AIM AND OBJECTIVES 
The aim of this study is to evaluate the effectiveness and cost-effectiveness of the SHIFT 
programme using a cluster RCT.  
 
Primary objective 
To investigate the impact of the SHIFT programme, compared to usual care, on objectively 
measured physical activity (expressed as steps/day) at 12-months follow-up. 
 
Secondary objectives 
To investigate the impact of the SHIFT programme, compared to usual care, at 12-months 
follow-up on; 
1. time spent in light and moderate-to-vigorous physical activity (MVPA) 
2. sitting time 
3. measures of adiposity (BMI, percent body fat, waist-hip ratio, neck circumference) 
4. blood pressure 
5. cardiometabolic risk markers (e.g. HBA1c, total cholesterol, HDL-C and LDL-C) 
6. fruit and vegetable intake 
7. sleep 
8. cognitive function and psychophysiological reactivity 
7 
 
9. psychosocial variables and mental health (e.g. anxiety and depression, work 
engagement, job performance and satisfaction, presenteeism, sickness absence, 
health-related quality of life, and driving related safety behaviour) 
We will also conduct a full process evaluation (secondary objective 10) and a full economic 
evaluation (secondary objective 11). 
 
METHODS AND ANALYSIS 
Design 
The design of this study is based on guidance from the UK Medical Research Council for 
developing and evaluating complex interventions,22 and this protocol paper has been 
prepared following the recommendations within the SPIRIT (Standard Protocol Items for 
Randomized Trials) statement.23 This is a workplace two-armed 12-month cluster RCT, 
which will incorporate an internal pilot, and include both economic and process 
evaluations. Clusters (different worksites/depots within the same company) will be 
randomised, following the completion of baseline measurements, to receive either the 
‘SHIFT programme’ or usual care condition. The impact of the intervention will be 
assessed at 6 and 12-months after randomisation. Figure 1 shows the overall trial design. 
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Figure 1. Trial design and participant flow through the study  
Study preparatory work with Health and Safety personal 
within Logistics company 
24 depots identified across the company 
Study briefings within participating depots 
Recruitment of study participants from 
participating depots 
Baseline measures in all participating 
depots 
Randomisation of depots, stratified by size 
Intervention depots (n=12 overall, 3 used 
in internal pilot) 
Control depots (n=12 overall, 3 used in 
internal pilot) 
Education sessions 
Intervention duration: 6 months 
Drivers given a Fitbit, 6-weekly ‘step count challenges’ 
(within individual competitions), equipment for the cab 
workout, health coach support 
Continue with usual practice 
6-month follow-up measures upon completion of the formal intervention period 
Ongoing process 
evaluation throughout 
intervention 
Recruitment of personnel 
within the company to 
undertake the education 
sessions 
Training of personnel to 
undertake the education 
sessions 
12-month follow-up measures after randomisation 
Drivers encouraged to continue with changes 
Recruitment and 
training of additional 
worksite champions 
Internal pilot conducted on 
the first 6 depots. Participant 
flow through the pilot will 
mirror the full trial as shown 
below 
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Setting 
This research will take place within the worksite setting of a major international Logistics 
and Transport company. The Logistics and Posts Sector is worth approximately £55 billion 
to the UK economy and currently employs approximately 1.7 million people. Driving is a 
fundamental occupation within this industry, and drivers and warehouse workers make up 
the majority of the workforce within the industry.15   
 
Depot recruitment and exclusion criteria 
Depots will be included in the study if they contain at least 20 long-distance HGV drivers 
(see sample size). Depots containing HGV drivers who make many delivery stops, for 
example, drivers who deliver consumer goods to domestic customers throughout the day 
will be excluded.  For logistical reasons, depots located within the Midlands region of the 
UK will be recruited. Our partner company has approximately 40 sites, containing 
approximately 1700 HGV drivers within this region. These sites are a similar size, and 
have a similar variation in size, to the company’s national-level data. During recruitment, 
depots will be informed that they will have a 50% chance of being randomised to a current 
practice control condition. 
 
Participant recruitment and exclusion criteria 
All HGV drivers within participating depots will be eligible to participate, unless they meet 
the following exclusion criteria: suffering from clinically diagnosed cardiovascular disease, 
or mobility limitations that prevent them from increasing their daily activity levels, 
haemophilia, or have any blood-borne viruses. Posters advertising the study will be placed 
in participating depots for up to four weeks prior to the scheduling of baseline 
measurements. In addition, all drivers within participating depots will receive a letter and 
participant information sheet informing them of the study. Following the distribution of the 
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study marketing material, researchers will visit participating depots for one to two days to 
enable interested drivers to ask any questions about the study before signing up. Upon 
completion of these visits the researchers will provide a list of drivers’ names who have 
agreed to participate to their Transport Managers who will then schedule time for 
participating drivers to attend the baseline (and follow-up) measurements.  
 
Within the UK logistics industry, 1% of HGV drivers are women,15 and the proportion of 
female HGV drivers employed by our partner company reflects this national average. 
Whilst females will be included in the study, due to the small proportion of the workforce 
they represent, the included sample of females may not enable statistically meaningful 
comparisons to examine any influences of sex on the intervention. However, the sample 
recruited, will likely reflect the gender disparities seen in the Logistics and Transport 
industry nationally and internationally.  
 
Sample size 
Our earlier exploratory pre-post study revealed that on average HGV drivers achieve 8786 
steps/day across both workdays and non-workdays with a standard deviation of 2919 
steps.20 We have powered this study to look for a difference in step counts (the primary 
outcome) of 1500 steps/day (equivalent to approximately 15 minutes of moderately paced 
walking) between the intervention group and control group. Evidence demonstrates a 
linear association between step counts and a range of morbidity and mortality outcomes, 
as well as with markers of health status including inflammation and adiposity, insulin 
sensitivity and HDL cholesterol in adults.24-26 The linear association between step counts 
and health outcomes indicate that regardless of an individual’s baseline value, even 
modest increases in daily step counts can yield clinically meaningful health benefits. For 
example, a difference in daily steps of 1500 steps/day has been associated with around a 
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5-10% lower risk of all-cause mortality and cardiovascular morbidity and mortality in the 
general population and in those with a high risk of type 2 diabetes respectively.27 28 The 
proposed level of change has been chosen based on findings from our exploratory pre-
post intervention,20 whilst also being clinically meaningful. 
 
Based on a cluster size of 10, a conservative ICC of 0.05 (as there is no previous data to 
inform this, we have been informed by recommendations of Campbell et al.29), an alpha of 
0.05, power of 80% and a coefficient of variation to allow for variation in cluster size of 
0.51 (based on partner company data) we will require 110 participants from 11 clusters per 
arm. From experience in conducting such studies, it is estimated that retention and 
compliance rates will be approximately 70% at 12-months follow-up; therefore, the sample 
size will be inflated by 30% to ensure we have adequate power in our final analysis. We 
will also inflate the number of clusters by 2 to allow for whole cluster drop out. We will 
therefore recruit 24 clusters with an average of 14 participants per cluster. 
 
Intervention  The SHIFT Programme 
The SHIFT programme is a multicomponent lifestyle-behaviour intervention designed to 
target behaviour changes in physical activity, diet and sitting in HGV drivers. This 6-month 
intervention, grounded within the Social Cognitive Theory for behaviour change30 consists 
of a group-based (4-6 participants) 6-hour structured education session tailored for HGV 
drivers, delivered by two trained educators. It includes information about physical activity, 
diet and sitting and risk factors for type 2 diabetes and cardiovascular disease. The 
educational component is founded on the approach used in the award winning suite of 
DESMOND programmes, including the PREPARE31 and Let’s Prevent Diabetes 
programmes,32 created by researchers at the Leicester Diabetes Centre and used 
throughout the NHS,33 whilst being tailored to meet the needs of HGV drivers.7  Within the 
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education session participants will not be ‘taught’ in a formal way, but supported to work 
out knowledge through group discussions and to develop individual goals and plans, 
based on detailed individual feedback received during their health assessments (see 
Measurements) to achieve over the 6-month intervention period. The education session is 
supported by specially developed resources for HGV drivers and participant support 
materials. The session will include the discussion of feasible strategies for participants to 
increase their physical activity, improve their diet and reduce their sitting time (when not 
driving) during working and non-working hours. The content of the educational session is 
summarised in Table 1. 
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Table 1. Outline of the educational component of the SHIFT programme 
 
During the education session, participants will be provided with a Fitbit® Charge 2 activity 
tracker and encouraged to use this to set goals (agreed at the session) to gradually 
increase their physical activity predominately through walking-based activity. The Fitbit® 
activity tracker will provide participants with information on their daily step counts and will 
be used as a tool for self-monitoring and self-regulation. Physical activity tracking using 
step counters (traditionally pedometers) has been associated with significant reductions in 
BMI and blood pressure, with interventions incorporating goal setting being the most 
effective.37  
Section name Theoretical 
underpinning 
Main aims and educator activities Duration 
(minutes)  
Welcome and 
Introduction 
 Participants introduced to the SHIFT 
programme and made aware of both 
content and style of the session. 
10 
Driver Story Dual Process 
theory,34 Common 
Sense Model35 
Participants asked about their beliefs about 
how being a HGV driver can affect health, 
the causes of these health problems and 
controllability of these. 
30 
Risks and Health 
problems 
Dual Process 
theory,34 Common 
Sense Model,35 
Social learning 
theory36 
Facilitator uses participant stories to support 
them to work out why they may be at risk of 
future health problems, and what to do to 
reduce/ manage risk 
55 
Physical Activity Dual Process 
theory,34 Social 
learning theory36 
Facilitator supports participants to develop 
knowledge and skills to support confidence 
to increase personal activity levels, to set 
personal goals and self-monitor through the 
use of Fitbits. Introduction and practical 
demonstration of the ‘cab-workout’. 
80 
Depression, 
Sleeping, Smoking 
Dual Process 
theory,34 Social 
learning theory36 
Facilitator supports participants to develop 
strategies to manage depression, poor 
sleep and smoking 
30 
Food Choices Dual Process 
theory,34 Social 
learning theory36 
Facilitator supports participants to develop 
knowledge and skills for food choices to 
reduce cardiovascular risk factors and 
improve overall health. 
90 
Self-management 
plan 
Dual Process 
theory,34 Social 
learning theory36 
Participants supported in developing 
personal self-management plans. 
15 
Questions 
 
Common Sense 
Model,35 Social 
learning theory36 
Facilitator checks all questions raised by 
participants throughout the programme 
have been answered and understood. 
5 
What happens next Social learning 
theory36 
Follow-up care outlined 5 
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The education session will adopt the promotion of the “small changes” philosophy using 
the Specific, Measurable, Attainable, Relevant, and Timely (SMART) principle38 to 
encourage participants to gradually build-up their daily activity levels, within the confines of 
their occupation, to meet the current UK Physical Activity guidelines.39 For example, 
participants will be encouraged to establish their own personalised action plan, which may 
also include making dietary improvements in addition to increases in physical activity, with 
SMART goals throughout the 6-month intervention. ‘Step count challenges’ (1-week 
competitions within intervention depots) will run every 6-weeks throughout the 6-month 
intervention which will be facilitated by local worksite champions. A “cab workout” will be 
introduced and practised at the education session and participants will be provided with 
resistance bands and balls, and grip strength dynamometers to take away. Participants will 
be encouraged to undertake the cab workout during breaks when not permitted to leave 
their vehicle. Participants will be able to keep the intervention tools beyond the 6-month 
intervention period, however the company will choose whether to sustain the worksite 
champion support and step count challenges beyond the 6-month intervention period. A 
Logic Model detailing the underlying theory behind the intervention components is shown 
in Figure 2.  
 
The structured education session will be delivered by trained personnel from our partner 
company and by trained members of the research team. These individuals will be trained 
and mentored by trainers from the Leicester Diabetes Centre. The education sessions will 
take place within appropriate training rooms within the intervention depots. Personnel 
delivering the education sessions within each intervention depot will also be trained to act 
as a local champion, shown to enhance the effectiveness of worksite physical activity 
interventions.40 They will provide ongoing health coach support to intervention participants 
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(during the 6-month intervention period) and be responsible for facilitating the step count 
challenges.  
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The SHIFT Programme is 
grounded within the Social 
Cognitive Theory for 
behaviour change, 
components of the theory 
applied to the intervention 
are as follows: 
Acquisition of essential 
knowledge relating to 
behaviour(s) and 
behavioural choices 
Physical environmental 
influences 
Creation of a supportive 
social environment 
Importance of self-efficacy 
& monitoring 
Underpinning theory Available resources and activities 
A theory-based education session, 
derived from the award-winning 
DESMOND programme, utilised 
throughout the NHS 
Evidence suggests education 
programmes with a theoretical basis 
are associated with improved 
outcome
 
 
Provision of resistance bands & balls 
& grip strength dynamometers for use 
in the cab workout – a popular activity 
reported by drivers in our pilot 
Health coach support - shown to 
enhance the effectiveness of PA 
interventions 
Recruitment of local champions - 
shown to enhance the effectiveness 
of worksite PA interventions 
Provision of free fruit – shown to be 
more effective than healthy packed 
lunches in our pilot 
PA tracker (pedometer) & goal setting 
– pedometer use has been associated 
with reductions in BMI 
Step count challenges (within & 
between participants) – shown to 
enhance pedometer interventions 
Short-term outputs/goals 
Enhanced knowledge of the 
importance of healthy lifestyle 
behaviours, including the benefits 
of PA, risks of prolonged sitting & 
healthy dietary choices 
Increased adoption of making use 
of otherwise sedentary times to 
engage in stretching related 
activities. The cab workout is 
designed to be undertaken during 
breaks when drivers are not 
permitted to leave their vehicle 
Increased adoption of healthy 
snacking behaviour 
Enhanced self-monitoring & goal 
setting, shown to enhance the 
effectiveness of pedometers to 
increase PA plus increased self-
efficacy 
Enhanced group motivation & 
sustainability for increased PA 
Increased social interaction & 
reinforcement 
Observational learning & modelling 
of healthy behaviours 
Longer-term outputs/goals 
  
Increased participation in PA 
& reduced sedentary time 
over 6-month intervention 
period 
Long-term adherence to 
increased PA & reduced 
sitting in the target 
population, along with 
improvements in snacking 
behaviour 
Improved health and well-
being in occupational drivers 
SHIFT intervention 
embedded into professional 
drivers CPC 
Sustained increase in PA & 
reduced sedentary time, plus 
improved diet, through 
increased self-efficacy, 
leading to health benefits at 
12 months follow-up 
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Control arm 
Depots assigned to the usual practice control arm will be asked to continue with their usual 
care conditions. Participants in the control depots will receive an educational leaflet at the 
outset detailing the importance of healthy lifestyle behaviours (i.e., undertaking regular 
physical activity, breaking up periods of prolonged sitting, and consuming a healthy diet) 
for the promotion of health and well-being. Control participants will be requested to 
complete the same study measurements as those in the intervention worksites, at the 
same time points. Upon completion of the study, control depots will be provided with all of 
the educational material provided to the intervention participants as part of the SHIFT 
programme. As the intervention will be delivered by trained personnel within our partner 
company, the company may choose to provide the full intervention (including the 
education session and health coach support) to control depots upon completion of the 
formal trial. 
 
Allocation to treatment groups 
Clusters (depots within the same company) will be randomised at the worksite level into 
the two study arms (intervention and control, using an allocation ratio of 1:1). 
Randomisation into the study arms will take place in two batches; initially the first 6 
clusters (depots) involved in the internal pilot (see below) will be randomised, and in the 
second batch all of the remaining clusters will be randomised stratified by depot size. 
Depots will be classified as either small or large based on the median cluster size of all 
participating depots. In both batches randomisation will take place upon completion of 
baseline measurements and will be done by an independent statistician at the Leicester 
Clinical Trials Unit (CTU).  
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Measurements 
The outcome measurements will be assessed at 3 time points. Baseline measures will 
occur prior to randomisation of the depots into the 2 study arms. A second set of identical 
measurements will take place 6-months post randomisation (i.e. just after the completion 
of the 6-month intervention), and a final set will be taken at 12-months post randomisation 
to assess the sustainability of the intervention (i.e. 6 months after completion of the formal 
intervention period, as recommended by the National Obesity Observatory41). At the 
baseline assessment, the study will be explained to the participant and written informed 
consent will be obtained. The measurements will be undertaken in suitable rooms within 
participating depots by trained researchers and will last between 1.5 and 2 hours per 
participant. Participants will complete a range of self-report questionnaires and have a 
series of physiological health assessments taken. All participants will receive detailed 
feedback on their physiological health assessment measures during each measurement 
session.  In the event that a potential health issue is evident during the health 
assessments, such as undiagnosed hypertension or high cholesterol levels, participants 
will be advised to visit their GP for further checks. We will provide participants with a letter 
to give to their GP which summarises the findings from our point-of-care (blood markers) 
and automated (blood pressure) measures. Participants will be requested to inform the 
researchers about the use of any prescribed medications that they commence throughout 
the study duration which may impact the proposed outcome measures. Participants will be 
issued with objective monitoring devices to assess their free-living physical activity, 
sedentary behaviour and sleep, which they will be instructed to wear for eight days 
following each measurement visit. After eight days, participants will be requested to return 
these monitors to their depot where they will be collected by a member of the research 
team. 
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Primary outcome 
The primary outcome will be physical activity, expressed as steps/day, at 12 months post 
randomisation. Physical activity will be objectively measured using the activPAL micro 
accelerometer, worn continuously on the anterior aspect of the thigh, for 24 hours/day over 
eight days during each assessment period. The activPAL provides a valid measure of 
walking and posture (i.e. sitting and standing) in adults,42-44 and provides a more accurate 
measure of physical activity and sitting in occupational drivers in comparison to waist-worn 
accelerometers.45 As the physical activity component of the intervention predominantly 
includes the promotion of walking based-activity, and as participants will be provided with 
a Fitbit providing information on daily step counts to set goals to increase their physical 
activity, steps/day was chosen as the primary physical activity related outcome.  
 
Secondary outcomes 
A number of secondary outcomes will be assessed at all measurement time points. The 
secondary outcomes are described below: 
 
Physical activity and sedentary behaviour 
Light and moderate-to-vigorous physical activity (MVPA) will be assessed using the 
activPAL and the wrist-worn GENEActiv accelerometer, both worn continuously for eight 
days. The GENEActiv is a lightweight waterproof device, resembling a sports watch, which 
has been found to be a valid and reliable objective measure of physical activity.46 
Outcomes calculated from the GENEActiv include minutes spent in MVPA, proportion of 
participants meeting the MVPA guidelines of 150 minutes per/week, total volume of 
physical activity regardless of intensity, and sleep duration. The accelerometer provides 
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time stamped data so activity at specific times of the day (e.g., during work, after work) will 
also be extracted. 
 
Sedentary behaviour will also be measured for 8 consecutive days during each 
assessment period using the activPAL3 micro. The activPAL is regarded as the most 
accurate method of assessing sitting behaviour in free-living settings,44 47 48 and is 
recommended for use in interventions when sitting is an outcome measure.43 From the 
data provided, we will extract total daily sitting time, work-time and leisure-time sitting, 
sitting bout durations, and number of transitions between sitting and standing. 
 
Sleep duration, subjective sleepiness and chronotype 
Sleep duration and efficiency will be measured objectively using the GENEActiv which has 
been shown to be an accurate measure of sleep, in addition to physical activity.49 
Subjective sleepiness will be assessed using the Karolinska Sleepiness Scale, shown to 
be a valid measure of sleepiness when validated against electroencephalography (EEG) 
and performance outcomes.50 51 Participants’ chronotype will be determined using the 
short version of the Morningness-Eveningness questionnaire.52 
 
Anthropometry, adiposity and blood pressure 
Stature (measured at baseline only) and body mass (both assessed without shoes), along 
with waist and hip circumferences, will be measured using standardised anthropometric 
techniques by trained research staff. BMI will be calculated as weight (kg)/height (m2).  
Body composition (percentage body fat and fat mass) will be assessed via bio-impedance 
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analysis, using Tanita DC-360S body composition scales. We will also measure neck 
circumference which is a novel marker which links strongly to obstructive sleep apnoea, 
insulin resistance and cardiovascular disease risk.53 Blood pressure will be measured from 
the left arm after a twenty minute period of quiet sitting using an automated recorder 
(Omron HEM-907), in accordance with current recommendations.54   
 
Biochemical assessments 
Finger-prick blood samples will be collected from participants, with participants being 
requested to fast for KRXUV prior to attending each health assessment. The ‘A1CNow®+ 
point-of-care analyser will be used to measure glycated haemoglobin which is a marker of 
long-term glucose regulation used in clinical care. Additionally, we will use the 
Cardiochek® point-of-care analyser to measure circulating cholesterol (total, HDL, LDL). 
Both of these systems are manufactured by PTS Diagnostics and possess analyte 
validation certificates from the International Federation of Clinical Chemistry and 
Laboratory Medicine.  
 
Functional fitness 
Grip strength will be assessed from both hands using the Takei Hand-Grip dynamometer 
(Takei Scientific Instruments Co., Ltd; Japan). Reduced muscular strength, as measured 
by grip strength, is associated with an increased risk of cardiovascular disease, and all-
cause and cardiovascular mortality.55 
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Cognitive function and psychophysiological reactivity 
The Stroop test will be administered over a five minute period using a validated software 
package to provide a measure of reaction time, sensitivity to interference and the ability to 
suppress an automated response - reading colour names in favour of naming the font 
colour.56 To examine psychophysiological reactivity, acute stress will be induced using a 
five-minute mirror-tracing task (Campden Instruments Ltd.), during which measures of 
blood pressure and heart rate will be taken.57 
 
Work-related psychosocial variables and mental health 
A series of self-report measures will be employed to characterise work-related health and 
mental health: musculoskeletal symptoms will be assessed using the Standardised Nordic 
Questionnaire;58 work engagement (characterized by vigour, dedication, and absorption) 
will be measured using the Utrecht Work Engagement Scale (UWES);59 occupational 
fatigue will be measured using the Occupational Fatigue Exhaustion Recovery (OFER 15) 
scale;60 job performance61 and job satisfaction62 will be measured using single-item 7-point 
Likert scales; sickness presenteeism will be assessed using a single-item questionnaire; 
participant’s perceptions of work demand and support will be assessed using four 
subscales from the Health and Safety Executive Management Standards Indicator Tool 
(HSE MSIT),63 and driving-related safety behaviour will be assessed using a 6-item 
measure.64 Anxiety and depression will be measured using the Hospital Anxiety and 
Depression Scale (HADS),65 and Social Isolation will be assessed using the 8-item Social 
Isolation short form from the Patient-Reported Outcomes Measurement Information 
System.66 67 Data on sickness absence will be collected via self-report and employer 
records and will include frequency and duration of self-certified and certified sickness. 
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Data on sickness absence will be collected from organisational records for 12 months prior 
to the intervention and for the 6-month intervention and follow-up periods. 
 
Health-related quality of life and health-related resource use 
The self-reported EQ5D68 will be completed by participants during each assessment 
period to inform the within-trial cost-effectiveness analysis (see cost-effectiveness). 
Participants will also complete a questionnaire, developed for this study, assessing health-
related resource use at the same time points.  
 
Demographics and additional lifestyle health-related behaviour measures 
At baseline we will collect basic demographic information for each participant including 
their date of birth, sex, ethnicity, highest level of education, marital status, postcode (to 
determine Index of Multiple Deprivation as an indicator of neighbourhood socio-economic 
status), working hours, years worked as a HGV driver, and years worked at our partner 
company. At each follow-up assessment, participants will be asked if there have been any 
changes in these variables. During each assessment, information on smoking status and 
typical alcohol intake will be gathered by self-report measures. Dietary quality, including 
fruit and vegetable intake, will be assessed using a short-form food frequency 
questionnaire.69   
 
Internal pilot 
We intend to conduct an internal pilot study using the first six clusters (depots). The 
internal pilot will examine issues surrounding worksite and participant recruitment, 
randomisation, compliance to the primary outcome, and retention rates at 6-months 
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following randomisation. After this period we will continue to the full trial if the following 
progression criteria are met: 
 All 24 depots required for the full sample size agree to take part in the study. Six 
depots will be selected to take part in the internal pilot (three will be randomised to the 
intervention arm and three to the control arm). This will demonstrate that depot recruitment 
and intervention delivery is on-track. 
 According to our criteria, 84 drivers will need to agree to participate in the internal 
pilot, based on an average of 14 participants per cluster. 
 An average of 75% of drivers opting into the study, randomised into the intervention 
arm, attend the education session across the 3 intervention depots. This figure is based on 
the intervention uptake rate seen in our exploratory pre-post intervention study (87%),20 
whilst also recognising that take-up rates tend to be lower when moving from an efficacy to 
a larger multi-centre effectiveness trial. 
 No more than 20% of participants fail to provide valid data for the primary outcome 
measure (activPAL-determined step counts) at baseline and at 6 months post 
randomisation or withdraw/are lost to follow-up during the six-month intervention phase. 
This threshold is necessary as study power requires total withdrawal or loss to follow-up of 
no higher than 30% during the six-month intervention and six-month follow-up (12 months 
post randomisation).  
If the final two progression criteria are not fully met, strategies to improve these metrics for 
the full trial will be discussed with the Trial Steering Committee and the study will progress 
based upon recommendations from this committee.  
 
Process evaluation 
The process evaluation will be used to help explain any discrepancies between expected 
and observed outcomes, to understand the influence of intervention components and 
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context on the observed outcomes, and to provide insight for any further intervention 
development and implementation.22 Throughout the intervention, we will monitor the reach, 
efficacy, adoption, implementation, and maintenance of the intervention using the RE-AIM 
framework.70 We will employ a variety of techniques (e.g., logbooks, questionnaires, 
interviews and focus groups) to inform our process evaluation. For example, Transport 
Managers (or their nominated facilitators) and educators/worksite champions from each 
site will report on a monthly basis if there were any organisational changes (e.g. job 
changes) or events which may affect participation. Self-report questionnaires provided to 
study participants will evaluate the various intervention components (e.g. education 
session, physical activity monitoring tool, cab workout). Interviews and focus groups with 
study participants will further examine engagement in the various components of the 
intervention, along with any perceived barriers or facilitators to participating in these 
components. Interviews and focus groups with worksite champions, HR staff, health and 
safety personnel and logistics timetabling and planning staff will further examine the 
intervention implementation. We will also document any environmental factors (e.g. 
movement of personnel between worksites/depots, potential contamination of the 
intervention through drivers in different groups meeting at service stations/customer 
distribution centres) that may have an influence on intervention effectiveness. Details of 
the process evaluation components are included in Table 2. 
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Table 2. Process evaluation plan for the SHIFT intervention 
Areas to measure General process questions Data source and data collection 
method 
Total numbers and sampling 
strategy/timescales 
Recruitment Number of depots/worksites invited to 
participate, and number agreeing 
 
 
Number of possible participants at each depot, 
number invited/recommended for participation, 
number opting in to the intervention  
 
Number of participants opting-out, dropping out 
and non-compliance to the primary outcome 
measure 
Project records, including the number of 
drivers within each depot approached 
 
Depot logs of staff numbers, project 
records, attendance records at 
measurements 
 
 
Participant attendance records, short 
questionnaires to explore reasons for 
non-participation, dropping out and non-
compliance 
On-going throughout the project 
Acceptability of 
randomisation and 
measurement tools 
How depots feel about being randomised to 
intervention / control arms 
 
Did participants find outcome assessments 
acceptable 
 
How did participants and logistics timetabling 
staff experience recruitment and timetabling of 
outcome assessments 
 
 
 
Focus groups with participants 
 
 
 
Interviews with local depot health and 
safety advisors/HR/timetabling staff 
 
~8 focus groups, or until data saturation is 
reached, with participants ~1 month following 
completion of baseline measures 
 
~8 interviews, or until data saturation is 
reached, with local depot health and safety 
advisors/HR/timetabling staff ~1 month after 
completion of baseline measures in their 
depots 
Intervention 
acceptability and 
fidelity - 
implementation 
Was the intervention implemented as planned 
 
 
 
How did participants and logistics timetabling 
staff experience scheduling the education 
sessions  
Interviews with personnel within our 
logistics partners who are trained as 
educators and implemented the 
education sessions  
 
Interviews with local worksite champions 
and timetabling staff within intervention 
depots 
 
Participant questionnaires 
 
Interviews with educators, the number of which 
will depend on the number of educators 
trained, and timetabling staff immediately 
following delivery of the education sessions 
 
Interviews with local champions 3 months into 
the intervention, immediately following the 
intervention (6 months), and at 9 and 12 
months 
 
Questionnaires administered after education 
sessions to participants  
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Areas to measure General process questions Data source and data collection 
method 
Total numbers and sampling 
strategy/timescales 
Intervention 
acceptability and 
fidelity - participation 
What proportion of the target group participated 
in the intervention, and what components of the 
intervention were preferred, did this differ 
between males and females 
 
What strategies were put in place by 
intervention participants to facilitate behaviour 
change 
Focus groups with intervention 
participants 
 
Attendance logs at education sessions 
and measurement visits 
 
Questionnaires and focus groups 
~8 focus groups, or until data saturation is 
reached, with participants immediately 
following completion of the intervention (6 
months) 
 
Brief questionnaires administered to all 
intervention participants at 6 months during 
health assessments 
Intervention 
sustainability 
What proportion of the target group maintained 
any changes in their health behaviours following 
the 6 month intervention period 
 
Were there any differences in sustainability 
between males and females 
 
 
Are the company going to continue with the 
intervention in some way 
Focus groups with intervention 
participants 
 
 
Questionnaires 
 
 
 
Interviews with health and safety 
personnel 
~8 focus groups, or until data saturation is 
reached, with participants at 10 months follow-
up (4 months after completion of the 
intervention. 
 
Brief questionnaires administered to all 
intervention participants at 12 months during 
health assessments 
 
Interviews at 12 months 
Intervention 
contamination 
Did movement of staff (e.g. participants, health 
and safety personnel) occur from intervention to 
control depots  
 
Did intervention drivers interact with control 
drivers at customer warehouses/distribution 
centres etc. 
 
Control depots to keep a log of any staff 
changes 
 
 
Focus groups with intervention and 
control participants 
 
Logs collected upon completion of the 12 
month follow-up assessments 
 
8 focus groups, or until data saturation is 
reached, with intervention and control 
participants immediately following completion 
of the intervention (6 months) and at 10 
months follow-up 
Unexpected events 
arising from the study 
Did intervention and control participants modify 
their behaviours based on information provided 
at the baseline health assessments? 
 
Did the health assessments prompt GP visits 
 
Did increased self-awareness of health status 
and constraints within the job lead to cognitive 
dissonance 
 
Did intervention participants change an existing 
activity-related behaviour for another as a result 
of participating in the study 
Focus groups, interviews and 
questionnaires delivered to intervention 
and control participants 
 
Questionnaires delivered to intervention and 
control participants 1 month after completion of 
the baseline health assessments 
 
8 focus groups, or until data saturation is 
reached, with intervention and control 
participants immediately following completion 
of the intervention (6 months) and at 10 
months follow-up 
 
One-to one interviews based on questionnaire 
and focus group responses at 1 and 10 
months 
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Patient and Public Involvement (PPI) 
This trial is the result of an earlier 3-year partnership between the research team and a 
large transport and logistics company (different to our partner in the present study) in the 
East Midlands, UK. The preparatory work which informed this study3 7 16 17 was instigated 
by the company who requested help in improving the lifestyle behaviours and health of 
their long-distance drivers who were proving difficult to engage. The SHIFT programme 
was developed in collaboration with long-distance HGV drivers and health and safety 
personnel working within the logistics sector. Following pilot testing, the intervention and 
outcome measures described within this protocol, have been refined following further input 
from drivers and associated stakeholders. A driver and manager working within the 
logistics sector will sit on our independent Trial Steering Committee and will provide 
invaluable insight into the design, set-up, conduct and dissemination of this research. 
Throughout the trial we will conduct regular PPI events with relevant stakeholders to gain 
feedback on the trial’s progress. The research team will also continue to work with the 
Chartered Institute of Logistics and Transport to facilitate research dissemination (articles, 
conferences, workshops) across the logistics and transport sector nationally and 
internationally.  
 
Data Analysis 
Statistical analysis - Internal pilot 
The average recruitment rate across depots, proportion of participants providing valid data, 
and attendance rate at the education sessions will be reported with 95% CI. The point 
estimates and 95% CIs will be compared to the progression criteria outlined above. 
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Statistical analysis - Main trial 
Average daily steps at 12-months will be compared by group using generalised estimating 
equation models adjusted for baseline values and waking wear time with an exchangeable 
correlation structure, which adjusts for clustering. For the primary analysis missing data 
will not be replaced (complete case analysis) but participants will be included in the 
intervention group in which their depots were randomised irrespective of the intervention 
actually received (modified intention-to-treat analysis). We have inflated our sample size 
by 30% to account for potential loss to follow-up and non-compliance with the primary 
outcome measure. We will compare the baseline characteristics of those who have 
complete primary outcome data and those who do not. A sensitivity analysis using multiple 
imputation will be performed to assess the impact of missing outcome data on the results 
found and to account for uncertainty associated with imputing data (full intention to treat 
analysis). The imputation will be carried out using the command MI in Stata. MI replaces 
missing values with multiple sets of simulated values to complete the data, performs 
standard analysis on each completed dataset, and adjusts the obtained parameter 
estimates for missing-data uncertainty using Rubin’s rules to combine estimates. The 
effect size will also be assessed by attendance excluding those who did not attend the full 
intervention (per-protocol analysis). Secondary outcomes and 6-month data will be 
analysed using similar methodology. 
 
Qualitative analyses 
Audio-recordings of interviews and focus groups with drivers, worksite champions, HR 
staff, health and safety personnel and logistics timetabling and planning staff will be 
transcribed verbatim and analysed using framework analysis,71 72 using the RE-AIM 
framework70 as the overarching framework. 
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Cost-effectiveness 
The economic analysis will consist of a cost-consequence analysis based on the observed 
results within the trial period and a cost-effectiveness analysis where differences between 
groups in the trial will be extrapolated to the longer term. For both analyses, costs in both 
arms will be estimated from a NHS and Personal Social Services (PSS) perspective 
(consistent with that used by NICE) as well as a wider public sector perspective. In each 
analysis, the cost of the SHIFT arm will include an estimate of the cost of the intervention 
(including the cost of training the educators), generated through a staff questionnaire 
completed at the end of each education session. 
 
Within-trial analysis 
Within the trial, resource use estimates will be collected from participant questionnaires 
and will include health related resource use as well as absence from employment. The 
health-related resource use will be based on a variant of the Client Service Receipt 
Inventory and will include services that this population are likely to utilise such as GPs and 
Practise nurse appointments, occupational health visitors and counsellors. Costs of 
resources will be calculated by applying published national unit cost estimates (e.g. NHS 
reference costs or PSSRU Unit costs of health and social care73 74), where available, to 
estimates of relevant resource use.  
 
A range of outcomes will be assessed in the trial including health related quality of life, 
measured using the EQ5D.68 The within trial analysis will present incremental results for 
the primary and secondary outcomes (including EQ5D) in both intervention and control 
arms and will be compared with the incremental costs measured above. We will also 
present the results in terms of the differences between the groups in time absent from 
work. Two analyses will be conducted, one including these productivity losses, the other 
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excluding them. This will allow decision makers to assess the importance of inclusion of 
these costs in the adoption decision. 
 
Longer-term analysis 
It is acknowledged that although there may be short term health benefits from the 
intervention, the longer-term effects of, for example, increased physical activity on diabetic 
status and number of cardiovascular events may be more important. We will therefore 
conduct a brief literature review to identify existing models that link short term endpoints 
(including physical activity) measured in the trial and longer-term quality of life. We have 
identified and utilised existing models75 linking physical activity to Quality Adjusted Life 
Years (QALYs) previously.  These models will be utilised to extrapolate costs and effects 
of the intervention beyond the trial period to a more appropriate time horizon. If appropriate 
an Incremental Cost-effectiveness Ratio for the extrapolated period will be reported using 
the QALY. As with the within-trial analysis, we will conduct analyses where productivity 
losses are included/excluded to assess the impact on decision making. Costs and effects 
will be discounted at the prevailing recommended rate (currently 1.5% per annum on both 
costs and effects), but will be the subject of sensitivity analysis to reflect the ongoing 
uncertainty around appropriate discount rates for public health interventions. To reflect the 
levels of uncertainty in parameter inputs we will conduct probabilistic sensitivity analyses; 
this will allow a characterisation of the uncertainty around the adoption decision which we 
will depict using cost-effectiveness acceptability curves. Sensitivity analyses will be 
performed to determine the robustness of the results to altering certain assumptions such 
as the discount rate or inclusion/exclusion of productivity losses. 
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DISCUSSION 
HGV drivers’ working environments are not conducive to a healthy lifestyle, despite this 
they are currently an underserved occupational group in terms of health promotion efforts 
and exhibit higher than nationally representative rates of obesity and related co-
morbidities.10 17 The health and wellbeing of professional drivers is of public concern given 
their health impacts the safety of all road users.5 17 Of concern, obese HGV drivers are 
approximately 50% more likely to have an accident than normal weight drivers,76 with 
accident rates increasing further in HGV drivers suffering from obstructive sleep apnoea, a 
prevalent condition in this occupational group.8 The present study will target health-related 
behaviours of this at-risk and underserved occupational group, with the goal of making a 
positive long-term impact on long-distance HGV drivers’ health. Given the current absence 
of resources available to tackle health inequalities within the transport sector, it is 
anticipated that if effective, the SHIFT programme could be scalable as a Continued 
Professional Competence (CPC) resource for HGV drivers nationally and internationally. 
This resource will likely be modifiable for use across other driving-related occupations. 
This could have a long-term impact on professional drivers’ health, lead to cost savings 
within the logistics and transport sector, and ultimately impact road safety for all road 
users.  
 
To our knowledge, this is the first RCT to examine the impact of a multicomponent 
intervention targeting individual and environmental barriers faced by HGV drivers to lead a 
healthy lifestyle. Strengths of the study include the robust RCT design, with randomisation 
at the depot/cluster level to reduce contamination. The large fully powered sample, 
objectively derived outcome measures, and six-month follow-up assessment after 
completion of the SHIFT programme are further strengths, along with the extensive 
process and economic evaluations.  
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